ZA746409B - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
ZA746409B
ZA746409B ZA00746409A ZA746409A ZA746409B ZA 746409 B ZA746409 B ZA 746409B ZA 00746409 A ZA00746409 A ZA 00746409A ZA 746409 A ZA746409 A ZA 746409A ZA 746409 B ZA746409 B ZA 746409B
Authority
ZA
South Africa
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Application number
ZA00746409A
Other languages
English (en)
Inventor
F Troxler
E Wiskott
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA746409B publication Critical patent/ZA746409B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00746409A 1973-10-08 1974-10-08 Improvements in or relating to organic compounds ZA746409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (no) 1973-10-08 1973-10-08

Publications (1)

Publication Number Publication Date
ZA746409B true ZA746409B (en) 1976-05-26

Family

ID=4399720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00746409A ZA746409B (en) 1973-10-08 1974-10-08 Improvements in or relating to organic compounds

Country Status (21)

Country Link
JP (1) JPS5082078A (no)
AT (1) ATA802974A (no)
AU (2) AU498889B2 (no)
BE (1) BE820789A (no)
CA (1) CA1021772A (no)
CH (1) CH581113A5 (no)
DD (1) DD114605A5 (no)
DE (1) DE2447756A1 (no)
DK (1) DK135766B (no)
ES (1) ES430759A1 (no)
FI (1) FI286374A (no)
FR (1) FR2247242B1 (no)
GB (1) GB1474775A (no)
HU (1) HU169126B (no)
IL (1) IL45797A (no)
NL (1) NL7413105A (no)
NO (1) NO743534L (no)
PH (1) PH11611A (no)
SE (1) SE7412310L (no)
SU (1) SU567403A3 (no)
ZA (1) ZA746409B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI760704A (no) * 1975-03-26 1976-09-27 Sandoz Ag
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
SE7804318L (sv) * 1977-05-02 1978-11-03 Merck & Co Inc Nya naftyridiner
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
WO2001091796A2 (en) 2000-06-01 2001-12-06 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
PH11611A (en) 1978-04-12
AU7413074A (en) 1976-04-15
CH581113A5 (no) 1976-10-29
FR2247242A1 (no) 1975-05-09
NO743534L (no) 1975-05-05
DD114605A5 (no) 1975-08-12
FI286374A (no) 1975-04-09
AU7408974A (en) 1976-04-15
ATA802974A (de) 1979-07-15
BE820789A (fr) 1975-04-07
DK514874A (no) 1975-06-09
DK135766B (da) 1977-06-20
DE2447756A1 (de) 1975-04-10
IL45797A0 (en) 1974-12-31
ES430759A1 (es) 1977-04-16
GB1474775A (en) 1977-05-25
IL45797A (en) 1978-04-30
JPS5082078A (no) 1975-07-03
AU7409074A (en) 1976-04-15
NL7413105A (nl) 1975-04-10
SE7412310L (no) 1975-04-09
FR2247242B1 (no) 1978-07-21
HU169126B (no) 1976-09-28
CA1021772A (en) 1977-11-29
AU498889B2 (en) 1979-03-29
SU567403A3 (ru) 1977-07-30
DK135766C (no) 1977-11-21

Similar Documents

Publication Publication Date Title
ZA751569B (en) Improvements in or relating to organic compounds
ZA744268B (en) Improvements in or relating to organic compounds
ZA746409B (en) Improvements in or relating to organic compounds
ZA741019B (en) Improvements in or relating to organic compounds
ZA742036B (en) Improvements in or relating to organic compounds
ZA741941B (en) Improvements in or relating to organic compounds
ZA747603B (en) Improvements in or relating to organic compounds
ZA746641B (en) Improvements in or relating to organic compounds
ZA74679B (en) Improvements in or relating to organic compounds
ZA746984B (en) Improvements in or relating to organic compounds
ZA744544B (en) Improvements in or relating to organic compounds
ZA746101B (en) Improvements in or relating to organic compounds
ZA742644B (en) Improvements in or relating to organic compounds
ZA745703B (en) Improvements in or relating to organic compounds
ZA744410B (en) Improvements in or relating to organic compounds
ZA74856B (en) Improvements in or relating to organic compounds
ZA743316B (en) Improvements in or relating to organic compounds
ZA741376B (en) Improvements in or relating to organic compounds
ZA74214B (en) Improvements in or relating to organic compounds
ZA748129B (en) Improvements in or relating to organic compounds
ZA747791B (en) Improvements in or relating to organic compounds
ZA745494B (en) Improvements in or relating to organic compounds
ZA745634B (en) Improvements in or relating to organic compounds
ZA746444B (en) Improvements in or relating to organic compounds
KR780000050B1 (en) Improvements in or relating to organic compounds